These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2102538)

  • 1. [Vaccines against the hepatitis B virus. The outstanding problems].
    Carreño V; Quiroga JA
    Rev Clin Esp; 1990 Oct; 187(5):247-8. PubMed ID: 2102538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B protective inoculation. The problem of inadequate anti-HB production].
    Dennhöfer L
    Dtsch Med Wochenschr; 1990 Oct; 115(41):1560-5. PubMed ID: 2209446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inoculation against hepatitis B. Vaccines, mechanism of action, duration of the inoculation protection and revaccination].
    Jilg W
    Dtsch Med Wochenschr; 1989 Apr; 114(15):596-8. PubMed ID: 2649350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Active vaccination against hepatitis-B virus infection in thalassemia].
    Goldfarb A; Shouval S; Mani N; Shraga S; Rachmilewitz E
    Harefuah; 1986 Nov; 111(10):273-7. PubMed ID: 2950034
    [No Abstract]   [Full Text] [Related]  

  • 5. [Duration of the immunoprophylaxis produced by hepatitis B vaccine].
    Hernández JM; Piqueras J; Esteban JI; Esteban R
    Med Clin (Barc); 1985 May; 84(17):714-5. PubMed ID: 4010375
    [No Abstract]   [Full Text] [Related]  

  • 6. Control measures against hepatitis B infection.
    Frösner GG; Franco E
    Ann Ist Super Sanita; 1987; 24(2):267-75. PubMed ID: 2969204
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Unsuccessful vaccination against hepatitis B].
    Jilg W
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1773. PubMed ID: 2146107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serologic indicators of the preventive activity of gamma globulin produced by the Warsaw Laboratory of Sera and Vaccines in 1972-1984 against viral hepatitis].
    Karwowska S; Kacperska E; Seyfried H; Nowosławski A
    Przegl Epidemiol; 1986; 40(2):193-9. PubMed ID: 2433711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serologic epidemiology of hepatitis B viral infection and observation on the immunologic effect of hepatitis B vaccine].
    Ge QY
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Mar; 22(2):92-4. PubMed ID: 3215090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2].
    Zeitz M
    Z Gastroenterol; 1990 Mar; 28(3):179-80. PubMed ID: 2140478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of controlling immunity after vaccination against hepatitis B].
    Eriksson I; Mares I
    Lakartidningen; 1989 Mar; 86(9):705. PubMed ID: 2522161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunogenicity and long-term effectiveness of the hepatitis B vaccine in newborns from HBsAg-positive mothers].
    Torres JM; Bruguera M; Fos E; Mayor A; Hierro FR
    Med Clin (Barc); 1990 Sep; 95(7):247-9. PubMed ID: 2149403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine].
    Ohryohji F; Umezu T; Ootsuka M; Kanda S
    Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological and clinical significance of pre-S antigens and corresponding antibodies in hepatitis B virus infection].
    Budkowska A; Pillot J
    Gastroenterol Clin Biol; 1990; 14(11):861-7. PubMed ID: 2276567
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 20. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.